Skip to content

Improving Embryogenesis by Adding Growth Factors to In Vitro Human Culture Media

Growth Factors Supplementation to Single-Step Culture Medium

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02426008
Acronym
GFSSSCM
Enrollment
426
Registered
2015-04-24
Start date
2015-05-01
Completion date
2016-03-31
Last updated
2018-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In Vitro Human Embryo Development

Brief summary

The investigators suppose that adding growth factors that had been found in the female tubal fluid and uterus to In Vitro single step culture media for human embryos might improve the the embryogenesis In Vitro and the clinical outcome of the resulting off spring.

Detailed description

The IVF culture media design and upgrade underwent many ideas during the last 3 decades, we suppose that adding growth factors ( Insulin-like growth factor I, Insulin-like growth factor II, transforming growth factor-beta and epidermal growth factor ) as a promoting growth factors to Lifeglobal culture media might improve embryo development in vitro so we decide to design a trial to compare the embryogenesis by sibling Oocytes of the same patient between to arm of the same culture media and the same culture condition but with one arm with growth factors and the other is traditional one and closely monitor the outcome within the 2 arms and record the results.

Interventions

OTHERGrowth Factors and Cytokine adding to embryo culture media
OTHERNo Intervention

Nothing to Add

Sponsors

Banon IVF Center Assiut, Egypt
CollaboratorOTHER
Ibn Sina Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* all patients

Exclusion criteria

* over 40 years old

Design outcomes

Primary

MeasureTime frame
Clinical Pregnancy rate ( % )3 months

Secondary

MeasureTime frame
ongoing Pregnancy rate ( % )6 months
rates of blastocyst formation and quality6 days of culture

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026